Oxytocin i.m./i.v. Versus Carbetocin i.v. in Elective Cesarean Sections
Status:
Unknown status
Trial end date:
2020-12-01
Target enrollment:
Participant gender:
Summary
Objective is to proof non-inferiority of intramyometrial and intravenous oxytocin application
compared to intravenous carbetocin for prevention of postpartum hemorrhage in planned,
uncomplicated cesarean deliveries.